PhRMA Agenda Includes Tort Reform; Common Ground With HMOs?
Executive Summary
Concern about health care costs should translate into support for reform of the medical malpractice and liability system, Pharmaceutical Research & Manufacturers of America Chairman Robert Essner (Wyeth) said in his inaugural address
You may also be interested in...
PhRMA Prepares To Make Case For “FDA Defense” In Malpractice Bill
A U.S. Chamber of Commerce survey on the impact of prescription drug product liability litigation could help the pharmaceutical industry shore up its case for inclusion of "FDA defense" language in any medical malpractice legislation enacted into law
PhRMA Prepares To Make Case For “FDA Defense” In Malpractice Bill
A U.S. Chamber of Commerce survey on the impact of prescription drug product liability litigation could help the pharmaceutical industry shore up its case for inclusion of "FDA defense" language in any medical malpractice legislation enacted into law
Medicare Rx Law Would Fundamentally Change, Not End, Drug Pricing Debate
A House proposal to fund federal cost-effectiveness trials of pharmaceuticals may be a sign of things to come if the Medicare prescription drug legislation is enacted this year